| Literature DB >> 32503281 |
Maria Joana Catarata1,2,3,4,5, Ricardo Ribeiro1,2,6,7, Maria José Oliveira1,2,4, Carlos Robalo Cordeiro3,8, Rui Medeiros4,5.
Abstract
The mechanistic involvement of the renin-angiotensin system (RAS) reaches beyond cardiovascular physiopathology. Recent knowledge pinpoints a pleiotropic role for this system, particularly in the lung, and mainly through locally regulated alternative molecules and secondary pathways. Angiotensin peptides play a role in cell proliferation, immunoinflammatory response, hypoxia and angiogenesis, which are critical biological processes in lung cancer. This manuscript reviews the literature supporting a role for the renin-angiotensin system in the lung tumor microenvironment and discusses whether blockade of this pathway in clinical settings may serve as an adjuvant therapy in lung cancer.Entities:
Keywords: hypoxia; lung cancer; renin-angiotensin; tumor microenvironment
Year: 2020 PMID: 32503281 DOI: 10.3390/cancers12061457
Source DB: PubMed Journal: Cancers (Basel) ISSN: 2072-6694 Impact factor: 6.639